Loading...

Cochlear Limited

CHEOF•PNK
Healthcare
Medical - Devices
$125.00
$0.00(0.00%)
U.S. Market opens in 4h 43m

Cochlear Limited (CHEOF) Stock Overview

Explore Cochlear Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.2B
P/E Ratio32.99
EPS (TTM)$4.11
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$129.45
3 Months$172.64
1 Year Target$201.07

CHEOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cochlear Limited (CHEOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $201.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.99 and a market capitalization of 8.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.58%
5-Day Change
-3.27%
1-Month Change
0.84%
3-Month Change
-33.34%
6-Month Change
-31.63%
Year-to-Date (YTD) Change
-25.84%
1-Year Change
-27.39%
3-Year Change
-26.04%
5-Year Change
-27.33%
All-Time (Max) Change
473.39%

Contact Information

https://www.cochlear.com
61 2 9428 6555
1 University Avenue, Sydney, NSW, 2109

Company Facts

4,996 Employees
IPO DateFeb 13, 2009
CountryAU
Actively Trading

Frequently Asked Questions